Literature DB >> 28447771

Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.

Florian Deisenhammer1,2, Michael Auer1, Harald Hegen1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28447771     DOI: 10.1056/NEJMc1702076

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  1 in total

1.  Tardive Reactivation of Progressive Multiple Sclerosis During Treatment with Biotin.

Authors:  Alexis Demas; Jean-Philippe Cochin; Clémence Hardy; Yvan Vaschalde; Bertrand Bourre; Pierre Labauge
Journal:  Neurol Ther       Date:  2019-12-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.